Cargando…

The new WHO classification of gastrointestinal neuroendocrine tumors and immunohistochemical expression of somatostatin receptor 2 and 5

The 2019 World Health Organization (WHO) classification of gastrointestinal tumors defines well-differentiated grade 3 neuroendocrine tumors, the mixed neuroendocrine-non-neuroendocrine tumors (MiNENs) and classifies goblet cell carcinoid as goblet cell adenocarcinoma. The expression of somatostatin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Popa, Oana, Taban, Sorina Maria, Pantea, Stelian, Plopeanu, Andrei Dorel, Barna, Robert Alexandru, Cornianu, Marioara, Pascu, Anca-Ariana, Dema, Alis Liliana Carmen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2021
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406677/ https://www.ncbi.nlm.nih.gov/pubmed/34475969 http://dx.doi.org/10.3892/etm.2021.10613

Ejemplares similares

Immunohistochemical expression of chemokine receptor in neuroendocrine neoplasms (CXCR4) of the gastrointestinal tract: a retrospective study of 71 cases
por: Popa, Oana, et al.
Publicado: (2021)

Unexpected diagnosis for a gastric polyp: Granular cell tumor: Case report and review of the literature
por: Taban, Sorina Maria, et al.
Publicado: (2021)

Poorly differentiated clusters and tumor budding are important prognostic factors in colorectal carcinomas
por: Jurescu, Aura, et al.
Publicado: (2022)

The impact of the COVID-19 pandemic on thyroid nodular disease: a retrospective study in a single center in the western part of Romania
por: Popa, Oana, et al.
Publicado: (2023)

Colorectal Carcinomas: Searching for New Histological Parameters Associated with Lymph Node Metastases
por: Jurescu, Aura, et al.
Publicado: (2023)

Sclerosing Extramedullary Hematopoietic Tumor (SEHT) Mimicking a Malignant Bile Duct Tumor-Case Report and Literature Review
por: Dema, Sorin, et al.
Publicado: (2021)

Multiple Primary Tumors Originating From the Prostate and Colorectum A Clinical-Pathological and Therapeutic Challenge
por: Dema, Sorin, et al.
Publicado: (2021)

Invasive Cutaneous Melanoma: Evaluating the Prognostic Significance of Some Parameters Associated with Lymph Node Metastases
por: Vița, Octavia, et al.
Publicado: (2023)

Prognostic significance of tumor immune microenvironment and immunotherapy: Novel insights and future perspectives in gastric cancer
por: Lazăr, Daniela Cornelia, et al.
Publicado: (2018)

The Impact of Artificial Intelligence in the Endoscopic Assessment of Premalignant and Malignant Esophageal Lesions: Present and Future
por: Lazăr, Daniela Cornelia, et al.
Publicado: (2020)

Different disease characteristics in young patients with colorectal cancer: a large retrospective study in a city in Romania
por: Gheju, Adelina, et al.
Publicado: (2021)

Prostate carcinomas mimicking a digestive malignancy
por: Dema, Sorin, et al.
Publicado: (2020)

Somatostatin and Somatostatin Receptors: From Signaling to Clinical Applications in Neuroendocrine Neoplasms
por: del Olmo-Garcia, Maria Isabel, et al.
Publicado: (2021)

Role of Somatostatin Signalling in Neuroendocrine Tumours
por: Rogoza, Olesja, et al.
Publicado: (2022)

Epigenetic regulation of somatostatin and somatostatin receptors in neuroendocrine tumors and other types of cancer
por: Klomp, M.J., et al.
Publicado: (2020)

Somatostatin-Dopamine Chimeric Molecules in Neuroendocrine Neoplasms
por: Cantone, Maria Celeste, et al.
Publicado: (2021)

Semi-automated evaluation of Ki-67 index in invasive ductal carcinoma of the breast
por: SUCIU, CRISTIAN, et al.
Publicado: (2014)

Somatostatin Receptor 2 Expression Profiles and Their Correlation with the Efficacy of Somatostatin Analogues in Gastrointestinal Neuroendocrine Tumors
por: Watanabe, Hirofumi, et al.
Publicado: (2022)

Radiolabeled Somatostatin Analogues for Diagnosis and Treatment of Neuroendocrine Tumors
por: Ambrosini, Valentina, et al.
Publicado: (2022)

Pulmonary neuroendocrine tumours and somatostatin receptor status: an assessment of unlicensed use of somatostatin analogues in the clinical practice
por: Kiesewetter, B., et al.
Publicado: (2022)

Comparison of somatostatin receptor expression in patients with neuroendocrine tumours with and without somatostatin analogue treatment imaged with [(18)F]SiTATE
por: Eschbach, Ralf S., et al.
Publicado: (2023)

Somatostatin Receptor-Based Molecular Imaging and Therapy for Neuroendocrine Tumors
por: Wang, Ling, et al.
Publicado: (2013)

Imaging Somatostatin Receptor Activity in Neuroendocrine-differentiated Prostate Cancer
por: Mori, Hiroshi, et al.
Publicado: (2018)

Somatostatin Analogues in the Treatment of Neuroendocrine Tumors: Past, Present and Future
por: Stueven, Anna Kathrin, et al.
Publicado: (2019)

Somatostatin receptor scintigraphy in the follow up of neuroendocrine neoplasms of appendix
por: Saponjski, Jelena, et al.
Publicado: (2020)

Distinct mechanisms of hypoglycaemia in patients with somatostatin‐secreting neuroendocrine tumours
por: Wiesli, Peter, et al.
Publicado: (2019)

Clinical usefulness of Somatostatin Receptor Scintigraphy in the Diagnosis of Neuroendocrine Neoplasms
por: Inaba, Yoshitaka, et al.
Publicado: (2022)

Prescription patterns of somatostatin analogs in patients with acromegaly and neuroendocrine tumors
por: Machado-Alba, J. E., et al.
Publicado: (2022)

Diagnosis of malignant biliary obstruction: pondering over the ERCP, MRCP and histology
por: Rațiu, Iulia, et al.
Publicado: (2022)

Immunohistochemical Expression and Localization of Somatostatin Receptor Subtypes in Androgen Ablated Prostate Cancer
por: Mazzucchelli, Roberta, et al.
Publicado: (2010)

Somatostatin receptors on neuroendocrine tumors--a way to intraoperative diagnosis and localization.
por: Ahlman, H., et al.
Publicado: (1994)

Definition of the role of somatostatin receptor scintigraphy in gastrointestinal neuroendocrine tumor localization.
por: Jensen, R. T., et al.
Publicado: (1997)

Efficacy and Safety of Everolimus plus Somatostatin Analogues in Patients with Neuroendocrine Tumors
por: Ge, Wenhao, et al.
Publicado: (2018)

Interaction between somatostatin analogues and targeted therapies in neuroendocrine tumor cells
por: Krug, Sebastian, et al.
Publicado: (2019)

Role of Somatostatin Receptor in Pancreatic Neuroendocrine Tumor Development, Diagnosis, and Therapy
por: Hu, Yuheng, et al.
Publicado: (2021)

Development of anti-somatostatin receptors CAR T cells for treatment of neuroendocrine tumors
por: Mandriani, Barbara, et al.
Publicado: (2022)

A Comparative Study of Non-Invasive Methods for Fibrosis Assessment in Chronic HCV Infection
por: Şirli, Roxana, et al.
Publicado: (2010)

Perspectives on the diagnostic, predictive and prognostic markers of neuroendocrine neoplasms (Review)
por: Ciobanu, Oana Alexandra, et al.
Publicado: (2021)

Patient And Nurse Experience Of Using Somatostatin Analogues To Treat Gastroenteropancreatic Neuroendocrine Tumors: Results Of The Somatostatin Treatment Experience Trial (STREET)
por: Ström, Torbjörn, et al.
Publicado: (2019)

Postmenopausal Breast Cancer in Women, Clinical and Epidemiological Factors Related to the Molecular Subtype: A Retrospective Cohort Study in a Single Institution for 13 Years. Follow-Up Data
por: Oprean, Cristina Marinela, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_16olvqb1ph4m22tmbqd2d6jm6m